Related Experiment Video
Updated: Jun 25, 2025

In Silico Modeling Method for Computational Aquatic Toxicology of Endocrine Disruptors: A Software-Based Approach Using QSAR Toolbox
Published on: August 28, 2019
Development of a probabilistic risk model for pharmaceuticals in the environment under population and wastewater
Samuel A Welch1, Merete Grung1, Anders L Madsen2
1Norwegian Institute for Water Research (NIVA), Oslo, Norway.
Abstract:
Preparing for future environmental pressures requires projections of how relevant risks will change over time. Current regulatory models of environmental risk assessment (ERA) of pollutants such as pharmaceuticals could be improved by considering the influence of global change factors (e.g., population growth) and by presenting uncertainty more transparently. In this article, we present the development of a prototype object-oriented Bayesian network (BN) for the prediction of environmental risk for six high-priority pharmaceuticals across 36 scenarios: current and three future population scenarios, combined with infrastructure scenarios, in three Norwegian counties. We compare the risk, characterized by probability distributions of risk quotients (RQs), across scenarios and pharmaceuticals. Our results suggest that RQs would be greatest in rural counties, due to the lower development of current wastewater treatment facilities, but that these areas consequently have the most potential for risk mitigation. This pattern intensifies under higher population growth scenarios. With this prototype, we developed a hierarchical probabilistic model and demonstrated its potential in forecasting the environmental risk of chemical stressors under plausible demographic and management scenarios, contributing to the further development of BNs for ERA. Integr Environ Assess Manag 2024;20:1715-1735. © 2024 The Authors. Integrated Environmental Assessment and Management published by Wiley Periodicals LLC on behalf of Society of Environmental Toxicology & Chemistry (SETAC).
More Related Videos
05:46Identification of Pharmaceuticals in The Aquatic Environment Using HPLC-ESI-Q-TOF-MS and Elimination of Erythromycin Through Photo-Induced Degradation
Published on: August 1, 2018
16:02Demonstration of the Sequence Alignment to Predict Across Species Susceptibility Tool for Rapid Assessment of Protein Conservation
Published on: February 10, 2023
Related Concept Videos
Analysis of Population Pharmacokinetic Data
Mechanistic Models: Compartment Models in Individual and Population Analysis
Model Approaches for Pharmacokinetic Data: Distributed Parameter Models
The distributed parameter models are specifically designed to account for variations and differences in some drug classes. This model is particularly useful for assessing regional concentrations of anticancer or...
Pharmacokinetic Models: Overview
There are three primary types of models: empirical, compartment, and physiological. Empirical models, with minimal...
Physiological Pharmacokinetic Models: Incorporating Hepatic Transporter-Mediated Clearance
A recent model describes pravastatin's hepatobiliary excretion,...
Pharmacokinetic Models: Comparison and Selection Criterion
Physiological models take a detailed approach by considering specific molecular processes. They can predict drug distribution, metabolism, and elimination changes, providing a comprehensive understanding of how drugs interact with the body.